Corporate governance
The company's corporate governance is based on the best world practices and the principles of professionalism, ethics and objectivity. Independent directors provide independent judgment and strategic vision. A detailed understanding of the market and the company’s potential is the contribution of experienced top managers.
Strategy formation
Board of Directors
Petr Bely
Chairman of the Board of Directors
Founder and Chairman of the Board of Directors, PROMOMED group.
Holder of Pirogov’s order for merits in pharmaceutical manufacturing. PhD in medicine with specialization in gastroenterology. Author of numerous scientific publications.
Working experience
More than 25 years of working experience in healthcare. In 2005 he created PROMOMED – the company that by now has become a leader on the Russian biopharmaceutical market, with its own innovational products and biotechnological solutions.
Petr Bely actively contributes to building human resource capacities for the future of the Russian pharmaceutical industry. He was at the very beginning of the initiatives to open the department of chemistry and technology of physiologically active substances and the most up-to-date educational and research laboratory of chemistry and pharmaceutical technologies at N.P. Ogarev Mordovia State University.
Education
o A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
Holder of Pirogov’s order for merits in pharmaceutical manufacturing. PhD in medicine with specialization in gastroenterology. Author of numerous scientific publications.
Working experience
More than 25 years of working experience in healthcare. In 2005 he created PROMOMED – the company that by now has become a leader on the Russian biopharmaceutical market, with its own innovational products and biotechnological solutions.
Petr Bely actively contributes to building human resource capacities for the future of the Russian pharmaceutical industry. He was at the very beginning of the initiatives to open the department of chemistry and technology of physiologically active substances and the most up-to-date educational and research laboratory of chemistry and pharmaceutical technologies at N.P. Ogarev Mordovia State University.
Education
o A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
Kirill Rubinsky
Member of the Board of Directors, Independent Director
Working experience
Investment banker with vast experience, professionally managing large assets. He is currently an international investor running his own projects, managing a portfolio of personally owned assets via a family office based in Zurich (Switzerland), investing them into real estate, media and venture companies.
Education
o Paris High School of Commerce
o Moscow institute (university) of international relations of the Ministry of Foreign Affairs of the Russian Federation
Investment banker with vast experience, professionally managing large assets. He is currently an international investor running his own projects, managing a portfolio of personally owned assets via a family office based in Zurich (Switzerland), investing them into real estate, media and venture companies.
Education
o Paris High School of Commerce
o Moscow institute (university) of international relations of the Ministry of Foreign Affairs of the Russian Federation
Igor Maev
Member of the Board of Directors, independent Director
Doctor of medical science, Professor, academician of Russian Academy of Sciences, Honored Scientist of the Russian Federation, laureate of the prize awarded by the Government of the Russian Federation in science and technology, laureate of the 2014 prize awarded by the Government of the Russian Federation in quality, holder of the “Excellence in healthcare” medal, holder of the order of Friendship and order of Honor, holder of awards by the President of the Russian Federation
Working experience
Prorector, scientific affairs – the first prorector, head of the department for propaedeutics of internal diseases and gastroenterology, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation.
Igor Mayev’s areas of interest include gastroenterology and hepatology. He is the founder of a scientific community investigating approaches to the diagnosis and treatment of upper gastrointestinal tract diseases, well known in Russia.
Igor Mayev is the author or coauthor of over 800 research publications. He is the member of the Faculty of the Russian Gastroenterology Association, member of the Faculty of the Supreme Attestation Commission, member of the Working Group on Education and Science within the Commission on state awards affiliated with the President of the Russian Federation, responsible for areas such as higher education and teaching, member of the editorial boards of the following journals: “Therapeutic archive”, “Clinical medicine”, “Russian journal of gastroenterology, hepatology, coloproctology”. “Experimental and clinical gastroenterology”, “Farmateka”, “Consilium Medicum”, “Herald of the Russian Academy of Medical Sciences”.
Education
o A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
Working experience
Prorector, scientific affairs – the first prorector, head of the department for propaedeutics of internal diseases and gastroenterology, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation.
Igor Mayev’s areas of interest include gastroenterology and hepatology. He is the founder of a scientific community investigating approaches to the diagnosis and treatment of upper gastrointestinal tract diseases, well known in Russia.
Igor Mayev is the author or coauthor of over 800 research publications. He is the member of the Faculty of the Russian Gastroenterology Association, member of the Faculty of the Supreme Attestation Commission, member of the Working Group on Education and Science within the Commission on state awards affiliated with the President of the Russian Federation, responsible for areas such as higher education and teaching, member of the editorial boards of the following journals: “Therapeutic archive”, “Clinical medicine”, “Russian journal of gastroenterology, hepatology, coloproctology”. “Experimental and clinical gastroenterology”, “Farmateka”, “Consilium Medicum”, “Herald of the Russian Academy of Medical Sciences”.
Education
o A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
Dejan Jovanovic
Member of the Board of Directors, independent Director
Holder of the Order “For merit in the national healthcare”
Working experience
More than 30 years of healthcare experience. As a Director General / Head of affiliate, he was responsible for business of the major global pharmaceutical companies in Russia and Eastern Europe (Astellas Pharma, ICN Pharmaceuticals, Sanofi, Abbott Laboratories).
He was at the foundation of one of the most important industry associations in the pharmaceutical market – Association of International Pharmaceutical Manufacturers (AIPM)
Awarded with the Certificate of Merit “For contribution in the development of the Institute research activity” of the Institute of Law and Comparative Legal Studies of the government of the Russian Federation, as well as the Certificate of Merit of the Ministry of Health of the Russian Federation.
Education
o Warsaw Medical University (Poland)
Working experience
More than 30 years of healthcare experience. As a Director General / Head of affiliate, he was responsible for business of the major global pharmaceutical companies in Russia and Eastern Europe (Astellas Pharma, ICN Pharmaceuticals, Sanofi, Abbott Laboratories).
He was at the foundation of one of the most important industry associations in the pharmaceutical market – Association of International Pharmaceutical Manufacturers (AIPM)
Awarded with the Certificate of Merit “For contribution in the development of the Institute research activity” of the Institute of Law and Comparative Legal Studies of the government of the Russian Federation, as well as the Certificate of Merit of the Ministry of Health of the Russian Federation.
Education
o Warsaw Medical University (Poland)
Yury Litvinenko
Member of the Board of Directors, independent Director
PhD in medicine with specialization in psychiatry
Working experience
More than 30 years of healthcare experience. His career included top leadership positions in the biggest global pharmaceutical companies: Sanofi, AstraZeneca, Chiesi Pharmaceuticals. Since 2021 he is involved in independent consulting projects in healthcare and pharmaceutics
Education
O N.I. Pirogov Russian National Medical Research University of the Ministry of Health of the Russian Federation
o Management Centre Europe (MCE) (Belgium)
o Ashridge College (United Kingdom)
o Bocconi University (Italy)
Working experience
More than 30 years of healthcare experience. His career included top leadership positions in the biggest global pharmaceutical companies: Sanofi, AstraZeneca, Chiesi Pharmaceuticals. Since 2021 he is involved in independent consulting projects in healthcare and pharmaceutics
Education
O N.I. Pirogov Russian National Medical Research University of the Ministry of Health of the Russian Federation
o Management Centre Europe (MCE) (Belgium)
o Ashridge College (United Kingdom)
o Bocconi University (Italy)
Mikhail Malinovsky
Member of the Board of Directors, non-executive Director
Working experience
Since 2021 he has been the head of the LECAP law firm. Since 2023 he has been the Chairman of the Committee on primary stock market affiliated with the Board of the Moscow Stock Exchange PJSC. He is the Head of the Foundation for the Development of Structural Bond Market “Vector of Technologies”. Member of the Board of Directors, investment company “Bitsa-Invest”. Mikhail Malinovsky specializes in markets of corporate stock and debt capital, structural products, finance regulation, private equity, corporate law / M&A. He contributes to the development of the Russian law system, taking part in preparing regulatory and legal initiatives within advisory boards and working groups affiliated with the Bank of Russia, self-regulating organization “National Financial Association”, MFC and the State Duma of the Russian Federation. He is a member of the Public Board of the Charity Foundation “Be human”.
Education
o O.E. Kutafin Moscow State Law University
o Russian Law of Private Law
o Institute of Law and Comparative Legal Studies of the government of the Russian Federation
Since 2021 he has been the head of the LECAP law firm. Since 2023 he has been the Chairman of the Committee on primary stock market affiliated with the Board of the Moscow Stock Exchange PJSC. He is the Head of the Foundation for the Development of Structural Bond Market “Vector of Technologies”. Member of the Board of Directors, investment company “Bitsa-Invest”. Mikhail Malinovsky specializes in markets of corporate stock and debt capital, structural products, finance regulation, private equity, corporate law / M&A. He contributes to the development of the Russian law system, taking part in preparing regulatory and legal initiatives within advisory boards and working groups affiliated with the Bank of Russia, self-regulating organization “National Financial Association”, MFC and the State Duma of the Russian Federation. He is a member of the Public Board of the Charity Foundation “Be human”.
Education
o O.E. Kutafin Moscow State Law University
o Russian Law of Private Law
o Institute of Law and Comparative Legal Studies of the government of the Russian Federation
Alexander Yefremov
Member of the Board of Directors
PhD in medicine with specialization in cardiology
Working experience
More than 30 years of healthcare experience. His professional ladder, through the entire sequence of career steps, culminated in positions such as General Manager of affiliate, managing several big diversified global pharmaceutical and device companies in Russia and the Commonwealth of the Independent Countries, including companies with localized manufacturing of medicines and vaccines, such as Novartis, Baxter, Sanofi, Roche, Bausch Health.
In 2021 he joined “PROMOMED DM" LLC team as the Executive Director. In April 2023 he became the Director General
Education
o S.M. Kirov Miitary Medical Academy
o Russian Academy of Civil Services affiliated with the president of the Russian Federation
o Harvard Business School (USA)
o IMD Business School (Switzerland)
Working experience
More than 30 years of healthcare experience. His professional ladder, through the entire sequence of career steps, culminated in positions such as General Manager of affiliate, managing several big diversified global pharmaceutical and device companies in Russia and the Commonwealth of the Independent Countries, including companies with localized manufacturing of medicines and vaccines, such as Novartis, Baxter, Sanofi, Roche, Bausch Health.
In 2021 he joined “PROMOMED DM" LLC team as the Executive Director. In April 2023 he became the Director General
Education
o S.M. Kirov Miitary Medical Academy
o Russian Academy of Civil Services affiliated with the president of the Russian Federation
o Harvard Business School (USA)
o IMD Business School (Switzerland)
Yury Troyankin
Member of the Board of Directors,
Working experience
More than 25 years of managing human resources, all the way from a specialist to a top manager in holding companies, leaders of the respective industry areas (banking/financial institute, oil industry, mechanic engineering, public utilities, construction and real estate, agriculture, consumer goods industry). Successful experience in organization building, shaping teams and talent management, transformation of corporate culture, strategic development and change management.
He joined the PROMOMED GROUP team in late 2020. His area of responsibilities include management of human resources, organizational development, transformation processes.
Education
o Moscow Physical and technical Institute
o G.V. Plekhanov Russian University of Economics o Thunderbird American Graduate School of International Management (USA)
More than 25 years of managing human resources, all the way from a specialist to a top manager in holding companies, leaders of the respective industry areas (banking/financial institute, oil industry, mechanic engineering, public utilities, construction and real estate, agriculture, consumer goods industry). Successful experience in organization building, shaping teams and talent management, transformation of corporate culture, strategic development and change management.
He joined the PROMOMED GROUP team in late 2020. His area of responsibilities include management of human resources, organizational development, transformation processes.
Education
o Moscow Physical and technical Institute
o G.V. Plekhanov Russian University of Economics o Thunderbird American Graduate School of International Management (USA)
Kira Zaslavskaya
Member of the Board of Directors,
Author of more than 50 research publications, with more than 20 patented inventions.
Working experience
More than 15 years of healthcare experience. She joined the PROMOMED GROUP team in 2009, with career ladder all the way from a sales representative to a top manager.
As PROMOMED’s Director, novel products, she is responsible for shaping the strategy of portfolio development, implementation of novel technologies of drug development, organization of non-clinical and clinical studies, launching products.
Kira Zaslavskaya has contributed to the implementation of PROMOMED’s hallmark projects, including an observational postmarketing study of Reduxin® efficacy and safety in routine clinical practice (the largest study in global endocrinology), development, studies and launching of a medicine to treat COVID-19 Areplivir® (favipiravir) in tablets and parenteral formulation.
Education
o D.I. Mendeleyev Russian Chemical and Technical University, cum laude
o A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, with specialization in “Organic and organoelement chemistry”
o MBA, PwC Academy
Working experience
More than 15 years of healthcare experience. She joined the PROMOMED GROUP team in 2009, with career ladder all the way from a sales representative to a top manager.
As PROMOMED’s Director, novel products, she is responsible for shaping the strategy of portfolio development, implementation of novel technologies of drug development, organization of non-clinical and clinical studies, launching products.
Kira Zaslavskaya has contributed to the implementation of PROMOMED’s hallmark projects, including an observational postmarketing study of Reduxin® efficacy and safety in routine clinical practice (the largest study in global endocrinology), development, studies and launching of a medicine to treat COVID-19 Areplivir® (favipiravir) in tablets and parenteral formulation.
Education
o D.I. Mendeleyev Russian Chemical and Technical University, cum laude
o A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, with specialization in “Organic and organoelement chemistry”
o MBA, PwC Academy
Implementation of the strategy
Corporate management
Alexander Efremov
Director General, PROMOMED PJSC
PhD in medicine with specialization in cardiology
Working experience
More than 30 years of healthcare experience. His professional ladder, through the entire sequence of career steps, culminated in positions such as General Manager of affiliate, managing several big diversified global pharmaceutical and device companies in Russia and the Commonwealth of the Independent Countries, including companies with localized manufacturing of medicines and vaccines, such as Novartis, Baxter, Sanofi, Roche, Bausch Health.
In 2021 he joined “PROMOMED DM" LLC team as the Executive Director. In April 2023 he became the Director General
Education
o S.M. Kirov Miitary Medical Academy
o Russian Academy of Civil Services affiliated with the president of the Russian Federation
o Harvard Business School (USA)
o IMD Business School (Switzerland)
Working experience
More than 30 years of healthcare experience. His professional ladder, through the entire sequence of career steps, culminated in positions such as General Manager of affiliate, managing several big diversified global pharmaceutical and device companies in Russia and the Commonwealth of the Independent Countries, including companies with localized manufacturing of medicines and vaccines, such as Novartis, Baxter, Sanofi, Roche, Bausch Health.
In 2021 he joined “PROMOMED DM" LLC team as the Executive Director. In April 2023 he became the Director General
Education
o S.M. Kirov Miitary Medical Academy
o Russian Academy of Civil Services affiliated with the president of the Russian Federation
o Harvard Business School (USA)
o IMD Business School (Switzerland)
Ilya Bardin-Denisov
Director General, PROMOMED DM LLC
Working experience
He joined the PROMOMED GROUP team in 2023 as Executive Director. In April 2023 he became the Director of Operations. In 2024 he became the Director General of the managing organization, PROMOMED DM LLC.
Education
o I.M. Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation
o MBA with specialization in “Management”, National research University “Higher School of Economics”
Yuriy Troyankin
Director, HR and organizational development
Working experience
More than 25 years of managing human resources, all the way from a specialist to a top manager in holding companies, leaders of the respective industry areas (banking/financial institute, oil industry, mechanic engineering, public utilities, construction and real estate, agriculture, consumer goods industry). Successful experience in organization building, shaping teams and talent management, transformation of corporate culture, strategic development and change management.
He joined the PROMOMED GROUP team in late 2020. His area of responsibilities include management of human resources, organizational development, transformation processes.
Education
o Moscow Physical and technical Institute
o G.V. Plekhanov Russian University of Economics o Thunderbird American Graduate School of International Management (USA)
More than 25 years of managing human resources, all the way from a specialist to a top manager in holding companies, leaders of the respective industry areas (banking/financial institute, oil industry, mechanic engineering, public utilities, construction and real estate, agriculture, consumer goods industry). Successful experience in organization building, shaping teams and talent management, transformation of corporate culture, strategic development and change management.
He joined the PROMOMED GROUP team in late 2020. His area of responsibilities include management of human resources, organizational development, transformation processes.
Education
o Moscow Physical and technical Institute
o G.V. Plekhanov Russian University of Economics o Thunderbird American Graduate School of International Management (USA)
Kira Zaslavskaya
Director, novel products
Author of more than 50 research publications, with more than 20 patented inventions.
Working experience
More than 15 years of healthcare experience. She joined the PROMOMED GROUP team in 2009, with career ladder all the way from a sales representative to a top manager.
As PROMOMED’s Director, novel products, she is responsible for shaping the strategy of portfolio development, implementation of novel technologies of drug development, organization of non-clinical and clinical studies, launching products.
Kira Zaslavskaya has contributed to the implementation of PROMOMED’s hallmark projects, including an observational postmarketing study of Reduxin® efficacy and safety in routine clinical practice (the largest study in global endocrinology), development, studies and launching of a medicine to treat COVID-19 Areplivir® (favipiravir) in tablets and parenteral formulation.
Education
o D.I. Mendeleyev Russian Chemical and Technical University, cum laude
o A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, with specialization in “Organic and organoelement chemistry”
o MBA, PwC Academy
Working experience
More than 15 years of healthcare experience. She joined the PROMOMED GROUP team in 2009, with career ladder all the way from a sales representative to a top manager.
As PROMOMED’s Director, novel products, she is responsible for shaping the strategy of portfolio development, implementation of novel technologies of drug development, organization of non-clinical and clinical studies, launching products.
Kira Zaslavskaya has contributed to the implementation of PROMOMED’s hallmark projects, including an observational postmarketing study of Reduxin® efficacy and safety in routine clinical practice (the largest study in global endocrinology), development, studies and launching of a medicine to treat COVID-19 Areplivir® (favipiravir) in tablets and parenteral formulation.
Education
o D.I. Mendeleyev Russian Chemical and Technical University, cum laude
o A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, with specialization in “Organic and organoelement chemistry”
o MBA, PwC Academy
Timofey Soloviev
Director, economy and finance
Working experience
More than 17 years of successful experience in financial units of global and Russian commercial corporations across different industries (pharmaceuticals, FMCG, construction). For the last 8 years he had leadership roles in financial units of global and Russian pharmaceutical corporations in the Russian Federation (AstraZeneca Pharmaceuticals, Generium JSC). He has vast experience in financial analysis and strategic long-term planning.
He joined the PROMOMED GROUP team in late 2022, responsible for managing the group’s financial and economic affairs.
Education
o Monash University (Australia)
More than 17 years of successful experience in financial units of global and Russian commercial corporations across different industries (pharmaceuticals, FMCG, construction). For the last 8 years he had leadership roles in financial units of global and Russian pharmaceutical corporations in the Russian Federation (AstraZeneca Pharmaceuticals, Generium JSC). He has vast experience in financial analysis and strategic long-term planning.
He joined the PROMOMED GROUP team in late 2022, responsible for managing the group’s financial and economic affairs.
Education
o Monash University (Australia)
